Drugs.com - FDA MedWatch Alerts

Baxter Issues Voluntary Nationwide Recall of One Lot of Heparin Sodium in 0.9% Sodium Chloride Injection Due to Potential for Elevated Endotoxin Levels

Audience: Healthcare Provider, Pharmacy, Consumer DEERFIELD, Ill., AUG. 5, 2024 – Baxter International Inc. (NYSE:BAX) is voluntarily recalling one lot of Heparin Sodium in 0.9% Sodium Chloride Injection to the consumer level due to the...

Feb 9, 2025 - 21:45
 0
Baxter Issues Voluntary Nationwide Recall of One Lot of Heparin Sodium in 0.9% Sodium Chloride Injection Due to Potential for Elevated Endotoxin Levels
Audience: Healthcare Provider, Pharmacy, Consumer DEERFIELD, Ill., AUG. 5, 2024 – Baxter International Inc. (NYSE:BAX) is voluntarily recalling one lot of Heparin Sodium in 0.9% Sodium Chloride Injection to the consumer level due to the...
Read More

Tags:

Previous Article

B. Braun Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injectio...

Next Article

FDA Warns Against Purchasing or Using Chemical Peel Skin Products Without Profes...

Related Posts

Public Safety Notification on Amniotic Fluid Eyedrops

Public Safety Notification on Amniotic Fluid Eyedrops

Feb 9, 2025  0

Endo USA, Inc. Issues Voluntary, Nationwide Recall of Adrenalin® Chloride Solution (EPINEPHrine Nasal Solution, USP) Due to the Potential for Administration Errors

Endo USA, Inc. Issues Voluntary, Nationwide Recall of A...

Feb 9, 2025  0

Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic Acid Solution for Injection (Preservative Free, Non-Corn) 500mg/mL Due to the Presence of Glass Particles

Staska Pharmaceuticals, Inc. Issues Recall of Ascorbic ...

Feb 9, 2025  0